<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0706222151
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        COXICAM
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MELOXICAM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        7.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24.3
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="RIYADH PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 407]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AC06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>COXICAM contains the active substance meloxicam. Meloxicam belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs) which are used to reduce inflammation and pain in joints and muscles.</p><p>COXICAM is used for the:&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Short-term treatment of flare-ups of osteoarthritis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Long-term treatment of</p><p>o&nbsp;&nbsp; Rheumatoid arthritis</p><p>Ankylosing spondylitis &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>DO NOT TAKE COXICAM IN THE FOLLOWING CIRCUMSTANCES:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During the last three months of pregnancy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Children and adolescents under 16 years of age</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergy (hypersensitivity) to meloxicam</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergy (hypersensitivity) to aspirin or other anti-inflammatory medicines (NSAIDs)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergy (hypersensitivity) to any of the other ingredients of this medicine (listed in section 6) any of the following signs after taking aspirin or other NSAIDs:</p><p>&uuml;&nbsp; Wheezing, chest tightness, breathlessness (asthma)</p><p>&uuml;&nbsp; Nasal blockage due to swellings in the lining in your nose (nasal polyps)</p><p>&uuml;&nbsp; Skin rashes/nettle rash (urticaria)</p><p>&uuml;&nbsp; Sudden skin or mucosal swelling, such as swelling around the eyes, face, lips, mouth or throat, possibly making breathing difficult (angioneurotic oedema)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After previous therapy with NSAIDs and history of</p><p>&uuml;&nbsp; Bleeding in your stomach or intestines</p><p>&uuml;&nbsp; Holes (perforations) in your stomach or intestines</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ulcers or a bleeding in your stomach or intestines</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent or history of stomach or peptic ulcers or bleeding (ulceration or bleeding occurring at least twice)</p><p>Severely impaired liver function</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non dialyzed severe kidney failure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recent bleeding in the brain (cerebrovascular bleeding)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any kind of bleeding disorders</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe heart failure</p><p>If you are unsure whether any of the above applies to you, please contact your doctor.</p><p><strong>Warnings and precautions </strong></p><p>Medicines such as COXICAM may be associated with a small increased risk of heart attack (myocardial infarction) or stroke (apoplexy). Any risk is more likely with high doses and prolonged treatment. Do not take more than the recommended dose. Do not take COXICAM for longer than it is prescribed for you (see section 3 &ldquo;How to take COXICAM&rdquo;).</p><p>If you have heart problems, previous stroke or think that you might be at risk of these conditions, you should discuss your treatment with your doctor or pharmacist. For example if you:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have high blood pressure (hypertension)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have high levels of sugar in the blood (diabetes mellitus)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Have high levels of cholesterol in the blood (hypercholesterolemia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Are a smoker Stop your treatment with COXICAM immediately as soon as you notice bleeding (causing tar-colored stools) or ulceration of your digestive tract (causing abdominal pain).</p><p>Potentially life-threatening skin rashes (Stevens Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of COXICAM, appearing initially as reddish target-like spots or circular patches often with central blisters on the trunk. Additional signs to look for include ulcers in the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes). These potentially life-threatening skin rashes are often accompanied by flu-like symptoms. The rash may progress to widespread blistering or peeling of the skin.</p><p>The highest risk for occurrence of serious skin reactions is within the first weeks of treatment. If you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of COXICAM, you must not be re-started on COXICAM at any time.</p><p>If you develop a rash or these skin symptoms, stop taking COXICAM, seek urgent advice from a doctor and tell him that you are taking this medicine.</p><p>COXICAM is not appropriate, if you require immediate relief from acute pain.</p><p>COXICAM may hide the symptoms of infection (e.g. fever). If you think you may have an infection you should see your doctor.</p><p><strong>Precautions for use </strong></p><p>As it will be necessary to adjust the treatment, it is important to ask your doctor&rsquo;s advice before you take COXICAM in case of:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; History of inflammation of the gullet (oesophagitis), inflammation of the stomach (gastritis) or a history of any other disease of the digestive tract, e.g. Crohn&rsquo;s Disease or Ulcerative Colitis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High blood pressure (hypertension)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Older age</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Heart, liver or kidney disease</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High levels of sugar in the blood (diabetes mellitus)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced blood volume (hypovolaemia) which may occur if you have a serious blood loss or burn, surgery or low fluid intake</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High potassium levels in the blood previously diagnosed by your doctor</p><p>Your doctor will need to monitor your progress whilst on treatment.</p><p><strong>Other medicines and COXICAM </strong></p><p>As COXICAM may affect or be affected by other medicines, tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>In particular, please tell your doctor or pharmacist if you are taking/have taken, or are using any of the following:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other NSAIDs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines which prevent blood clotting</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines which break down blood clots (thrombolytics)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat heart and kidney diseases</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corticosteroids (e.g. used against inflammation or allergic reactions)</p><p>C<span style="text-align:unset">yclosporine used after organ transplants, or for severe skin conditions, rheumatoid arthritis or nephrotic syndrome</span></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any diuretic medicine (&ldquo;water tablets&rdquo;) your doctor may monitor your kidney function if you are taking diuretics.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicine to treat high blood pressure (e.g. Beta-blockers)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lithium &ndash; used to treat mood disorders</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Selective Serotonin re-uptake inhibitors (SSRIs) &ndash; used in the treatment of depression</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methotrexate &ndash; used to treat tumours or severe uncontrolled skin conditions and active rheumatoid arthritis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cholestyramine &ndash; used to lower cholesterol levels</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are a woman who uses an intrauterine contraceptive device (IUD), usually known as a coil</p><p>If in doubt, ask your doctor or pharmacist.</p><p><strong>Fertility </strong></p><p>COXICAM may make it more difficult to become pregnant. You should inform your doctor if you are planning to become pregnant or if you have problems to become pregnant.</p><p><strong>&nbsp;</strong></p><p><strong>Pregnancy Breast-feeding</strong><strong> </strong></p><p><strong>&nbsp;</strong></p><p>Do not take <strong>COXICAM</strong> if you are in the last 3 months of pregnancy because it may harm your unborn baby or cause problems at birth.&nbsp; <strong>It can cause kidney and heart problems for your unborn baby.&nbsp; It may affect the tendency for you and your baby to bleed and cause labor to be later or later than expected.&nbsp;</strong></p><p>&nbsp;</p><p>&nbsp;You should not take <strong>COXICAM</strong> during the first 6 months of pregnancy unless absolutely necessary and <strong>advised by your doctor</strong>.&nbsp; If you need treatment during this period or while you are trying to get pregnant, the lowest dose should be used for the shortest possible time.&nbsp; <strong>If taken for more than a few days from 20 weeks of pregnancy onwards. COXICAM</strong> <strong>can cause kidney problems in your unborn baby, which could lead to low levels of the amniotic fluid that surrounds the baby (oligohydramnios) or narrowing of the blood vessels (ductus arteriosus) in the baby&#39;s heart.&nbsp; If you need treatment for longer than a few days, your doctor may recommend additional monitoring.</strong><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines </strong></p><p>Visual disturbances, including blurred vision, dizziness, drowsiness, vertigo or other central nervous system disturbances may occur with this product. If affected do not drive or operate machinery.</p><p><strong>Important information about some of the ingredients of COXICAM</strong></p><p>COXICAM contains lactose and cellulose which are types of sugars. If you have been told you have intolerance to some sugars ask your doctor before taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p><strong>The recommended dose is: </strong></p><p><strong>Flare-ups of osteoarthritis: </strong></p><p>7.5 mg once a day. This may be increased to 15 mg once a day.</p><p><strong>Rheumatoid arthritis:</strong></p><p>15 mg once a day. This may be reduced to 7.5 mg once a day.</p><p><strong>Ankylosing spondylitis:</strong></p><p>15 mg once a day. This may be reduced to 7.5 mg once a day.</p><p>The tablets should be swallowed with water, or another drink, during a meal.</p><p><strong>Do not exceed the recommended maximum dose of 15 mg a day. </strong></p><p>If any of the statements listed under the heading &ldquo;<strong>Warnings and precautions</strong>&rdquo; apply to you, your doctor may restrict your dose to 7.5 mg once a day.</p><p><strong>COXICAM should not be given to children and adolescents under 16 years of age. </strong></p><p>If you feel that the effect of COXICAM is too strong or too weak, or if after several days you do not feel any improvement in your condition, talk to your doctor or pharmacist.</p><p><strong>If you take more COXICAM than you should</strong></p><p><strong>Whether you have taken too many tablets or suspect an overdose, contact your doctor or go to your nearest hospital immediately. </strong></p><p><strong>Symptoms following acute NSAID overdose are usually limited to:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lack of energy (lethargy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drowsiness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick (nausea) and being sick (vomiting)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pain in the area of the stomach (epigastric pain)</p><p>These symptoms generally get better when you stop taking COXICAM. You may suffer from bleeding of the stomach or intestines (gastrointestinal bleeding).</p><p><strong>Severe poisoning may result in serious drug reaction (see section 4.): </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High blood pressure (hypertension)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute kidney (renal) failure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Liver (hepatic) dysfunction</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction/flattening or standstill of breathing (respiratory depression)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of consciousness (coma)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Seizures (convulsions)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Collapse of the blood circulation (cardiovascular collapse)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Standstill of the heart (cardiac arrest)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Immediate allergic (hypersensitivity) reactions, including:</p><p>o&nbsp;&nbsp; Fainting</p><p>o&nbsp;&nbsp; Shortness of breath</p><p>o&nbsp;&nbsp; Skin reactions</p><p><strong>If you forget to take COXICAM </strong></p><p>Do not take a double dose to make up for a forgotten dose. Just take the next dose at the usual time.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The use of some non-steroidal anti-inflammatory drugs (NSAIDs) may be associated with a small increased risk of occlusion of arterial vessels (arterial thrombotic events), e.g. heart attack (myocardial infarction) or stroke (apoplexy), particularly at high doses and in long term treatment.</p><p>Fluid retention (oedema), high blood pressure (hypertension) and heart failure (cardiac failure) have been reported in association with NSAID treatment.</p><p>The most commonly-observed side effects affect the digestive tract (gastrointestinal events):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ulcers of the stomach and upper part of the small bowels (peptic/gastro-duodenal ulcers)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A hole in the wall of the bowels (perforation) or bleeding of the digestive tract (sometimes fatal, particularly in the elderly)</p><p>The following side effects have been reported after NSAID administration:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick (nausea) and being sick (vomiting)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loose stools (diarrhoea)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flatulence</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Constipation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indigestion (dyspepsia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abdominal pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tar-coloured stool due to bleeding in the digestive tract (melaena)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting of blood (haematemesis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation with building of ulcers in the mouth (ulcerative stomatitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Worsening of inflammation of the digestive tract (e.g. exacerbation of colitis or Crohn&rsquo;s disease)</p><p>Less frequently, inflammation of the stomach (gastritis) has been observed.</p><p><strong>Side effects of meloxicam &ndash; the active substance of COXICAM </strong></p><p><strong>Very common: affects more than 1 user in 10</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Gastrointestinal adverse events such as indigestion (dyspepsia), feeling sick (nausea) and being sick (vomiting), abdominal pain, constipation, flatulence, loose stools (diarrhoea)</p><p><strong>Common: affects 1 to 10 users in 100</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache</p><p><strong>Uncommon: affects 1 to 10 users in 1,000</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness (light-headedness)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A feeling of dizziness or spinning (vertigo)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Somnolence (drowsiness)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anaemia (reduction of the concentration of the red blood pigment haemoglobin)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in blood pressure (hypertension)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flushing (temporary redness of the face and neck)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium and water retention</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased potassium levels (hyperkalaemia). This can lead to symptoms such as:</p><p>o&nbsp;&nbsp; Changes to your heartbeat (arrythmias)</p><p>o&nbsp;&nbsp; Palpitations (when you feel your heartbeat more than usual)</p><p>o&nbsp;&nbsp; Muscle weakness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Eructation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the stomach (gastritis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bleeding of the digestive tract</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the mouth (stomatitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Immediate allergic (hypersensitivity) reactions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching (pruritus)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling caused by fluid retention (oedema), including swollen ankles/legs (oedema of the lower limbs)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sudden skin or mucosal swelling, such as swelling around the eyes, face, lips, mouth or throat, possibly making breathing difficult (angioneurotic oedema)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Momentary disturbance of liver function tests (e.g. raised liver enzymes like transaminases or an increase of the bile pigment bilirubin). Your doctor can detect these using a blood test.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disturbance of laboratory tests investigating kidney (renal) function (e.g. raised creatinine or urea)</p><p><strong>Rare: affects 1 to 10 users in 10,000</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mood disorders</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nightmares</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal blood count, including:</p><p>o&nbsp;&nbsp; Abnormal differential blood count</p><p>o&nbsp;&nbsp; Decreased number of white blood cells (leucocytopenia)</p><p>o&nbsp;&nbsp; Decreased number of blood platelets (thrombocytopenia)</p><p>These side effects may lead to increased risk of infection and symptoms such as bruising or nosebleeds.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ringing in the ear (tinnitus)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling your heartbeat (palpitations)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ulcers of the stomach or upper part of the small bowels (peptic/gastro-duodenal ulcers)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the gullet (oesophagitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Onset of asthma attacks (seen in people who are allergic to aspirin or other NSAIDs)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe blistering of the skin or peeling (Stevens- Johnson syndrome and toxic epidermal necrolysis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nettle rash (Urticaria)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Visual disturbances including:</p><p>o&nbsp;&nbsp; Blurred vision</p><p>o&nbsp;&nbsp; Conjunctivitis (inflammation of the eyeball or eyelids)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the large bowel (colitis)</p><p><strong>Very rare: affects less than 1 user in 10,000 </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blistering reactions of the skin (bullous reactions) and erythema multiforme. Erythema multiforme is a serious allergic skin reaction causing spots, red welts or purple or blistered areas. It can also affect the mouth, eyes and other moist body surfaces.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the liver (hepatitis). This can cause symptoms such as:</p><p>o&nbsp;&nbsp; Yellowing of the skin or the eyeballs (jaundice)</p><p>o&nbsp;&nbsp; Pain of the abdomen</p><p>o&nbsp;&nbsp; Loss of appetite</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute failure of the kidneys (renal failure) in particular in patients with risk factors such as heart disease, diabetes or kidney disease</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A hole in the wall of the bowels (perforation)</p><p><strong>Not known: frequency cannot be estimated from the available data</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Confusion</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disorientation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shortness of breath and skin reactions (anaphylactic/anaphylactoid reactions) rashes caused by exposure to sunlight (photosensitivity reactions)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Heart failure (cardiac failure) has been reported in association with NSAID treatment</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Complete loss of specific types of white blood cells (agranulocytosis), especially in patients who take COXICAM together with other drugs that are potentially inhibitory, depressant or destructive to a component of the bone marrow (myelotoxic drugs). This can cause:</p><p>o&nbsp;&nbsp; Sudden fever</p><p>o&nbsp;&nbsp; Sore throat</p><p>o&nbsp;&nbsp; Infections</p><p><strong>Side effects caused by non-steroidal anti-inflammatory medicines (NSAIDs), but not yet seen after taking COXICAM</strong></p><p>Changes to the kidney structure resulting in acute kidney failure:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare cases of kidney inflammation (interstitial nephritis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Death of some of the cells within the kidney (acute tubular or papillary necrosis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Protein in the urine (nephrotic syndrome with proteinuria)</p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date which is stated on the blister strip and outer carton. The expiry date refers to the last day of that month.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store below 30 &deg;C. protect from light</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store in the original package in order to protect from moisture.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What COXICAM contains:</p><p><strong>Tablets: </strong></p><p>Each tablet contains Meloxicam (BP) 7.5 mg or 15 mg.</p><p>Other ingredients: Microcrystalline Cellulose PH 102, Lactose, Povidone (K30), Colloidal Anhydrous Silica, Crospovidone, Sodium Citrate and Magnesium Stearate.</p><p><strong>&nbsp;</strong></p><p><strong>PRESENTATION: </strong></p><p><strong>7.5 mg tablets: </strong>Greenish light yellow coloured, biconvex circular tablets, having RP 16 on one side, and break line on the other side.<strong> </strong></p><p><strong>15 mg tablets: </strong>Greenish light yellow coloured, flat circular belvelled edged tablets, having RP 20 on one side, and break line on the other side.</p><p><strong>&nbsp;</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What COXICAM contains: 
Tablets: 
Each tablet contains Meloxicam (BP) 7.5 mg or 15 mg.
Other ingredients: Microcrystalline Cellulose PH 102, Lactose, Povidone (K30), Colloidal Anhydrous Silica, Crospovidone, Sodium Citrate and Magnesium Stearate.

PRESENTATION: 
7.5 mg tablets: Greenish light yellow coloured, biconvex circular tablets, having RP 16 on one side, and break line on the other side. 
15 mg tablets: Greenish light yellow coloured, flat circular belvelled edged tablets, having RP 20 on one side, and break line on the other side.

Tablets:  Packs contain (10) tablets of COXICAM 7.5 mg or 15 mg.
               Packs contain (30) tablets of COXICAM 7.5 mg.
                Hospital packs of COXICAM tablets 7.5 mg and 15 mg.



            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)</p><p>P.O.Box 442, Riyadh 11411</p><p>Fax: +966 11 265 0505</p><p>Email: contact@riyadhpharma.com</p><p><em>For any information about this medicinal product, please contact the local representative of marketing authorisation holder:</em></p><p>Saudi Arabia</p><p>Marketing department</p><p>Riyadh</p><p>Tel: +966 11 265 0111</p><p>Email: marketing@riyadhpharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                10/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">كوكسيكام يحتوي على المادة الفعالة ميلوكسيكام. ميلوكسيكام تنتمي إلى مجموعة من الأدوية تسمى العقاقير المضادة للالتهاب غير الستيرويدية (المسكنات) والتي تستخدم لتخفيف الالتهاب والألم في المفاصل والعضلات.</p><p dir="RTL">يستخدم كوكسيكام للاغراض التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج قصير المدى لاحتدام نوبات هشاشة العظام</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج طويل المدى لحالات</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب المفاصل الروماتويدي</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الفقرات الروماتويدي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تأخذ كوكسيكام في الحالات التالية:</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>خلال الأشهر الثلاثة الأخيرة من الحمل</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الأطفال والمراهقين تحت سن 16 سنة من العمر</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الحساسية (فرط الحساسية) لميلوكسيكام</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الحساسية (فرط الحساسية) من الأسبرين أو الأدوية المضادة للالتهابات الأخرى (المسكنات)</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الحساسية (فرط الحساسية) إلى أي من المكونات الأخرى من هذا الدواء (المدرجة في القسم 6) أي من العلامات التالية بعد تناول الأسبرين أو مضادات الالتهاب غير الستيرويدية الأخرى:</p><p dir="RTL">&uuml;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصفير، وضيق في الصدر، ضيق في التنفس (الربو)</p><p dir="RTL">&uuml;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انسداد الأنف يرجع إلى تورمات في بطانة الأنف (الزوائد الأنفية)</p><p dir="RTL">&uuml;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي / طفح القراص (الأرتيكاريا)</p><p dir="RTL">&uuml;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التورم المفاجئ للجلد أو الغشاء المخاطي ، مثل التورم حول العينين والوجه والشفتين والفم أو الحلق، وربما يسبب صعوبة التنفس (وذمة وعائية عصبية)</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>بعد علاج سابق بمضادات الالتهاب غير الستيرويدية وحدوث</p><p dir="RTL">&uuml;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف في المعدة أو الأمعاء</p><p dir="RTL">&uuml;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فتحات (ثقوب) في المعدة أو الأمعاء</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>قرحة المعدة أو نزيف في المعدة أو الأمعاء</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا كان لديك تاريخ أو حدث مؤخرا نزيف من المعدة أو قرحة هضمية (تقرح أو نزيف حدث مرتين على الأقل)</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>ضعف شديد بوظائف الكبد</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الفشل الكلوي الحاد بدون غسيل الكلى</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>نزيف حديث في الدماغ (النزيف الدماغي الوعائي)</p><p>اي نوع من النزيف</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>فشل القلب الحاد</p><p dir="RTL">إذا كنت غير متأكد ما إذا كان أي من أعلاه ينطبق عليك، يرجى الاتصال بالطبيب.</p><p dir="RTL"><strong>التحذيرات والاحتياطات </strong></p><p dir="RTL">الأدوية مثل كوكسيكام قد تكون مرتبطة بزيادة صغيرة بخطر حدوث النوبات القلبية (احتشاء عضلة القلب) أو السكتة الدماغية (السكتة). أي خطر من المرجح ان يكون مع جرعات عالية والعلاج لفترات طويلة. لا تأخذ أكثر من الجرعة الموصى بها. لا تأخذ كوكسيكام لفترة أطول مما يوصف لك (انظر القسم 3 &quot;طريقة استخدام كوكسيكام&quot;).</p><p dir="RTL">إذا كان لديك مشاكل في القلب، أو سكتة دماغية سابقة أو تعتقد أنك قد تكون في خطر من هذه الحالات، يجب عليك مناقشة العلاج مع طبيبك أو الصيدلي. على سبيل المثال إذا كنت:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك ارتفاع ضغط الدم (ارتفاع ضغط الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك مستويات عالية من السكر في الدم (داء السكري)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك مستويات عالية من الكولسترول في الدم (الكولسترول)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مدخنا ،أوقف العلاج بكوكسيكام فورا بمجرد ملاحظة النزيف (يسبب براز بلون القطران) أو تقرح الجهاز الهضمي (يسبب آلام في البطن).</p><p dir="RTL">تم الإبلاغ مع استخدام كوكسيكام عن طفح جلدي له احتمالية أن يكون مهدداً للحياة (متلازمة ستيفنز جونسون، انحلال البشرة السمي)، والذي يظهر في البداية على شكل بقع حمراء تشبه هدف الرماية أو بقع دائرية في كثير من الأحيان مع ظهور بثور بمركزها على الجذع. علامات إضافية يُبحث عنها تشمل تقرحات في الفم والحلق والأنف والأعضاء التناسلية والتهاب الملتحمة (أحمرار و انتفاخ العيون). وغالبا ما يصاحب هذه الطفح الجلدي المهدد للحياة أعراض شبيهة بأعراض الانفلونزا. الطفح الجلدي قد يتطور إلى ظهور تقرحات أو تقشير الجلد على نطاق واسع.</p><p dir="RTL">الخطر الأكثر لحدوث هذه التفاعلات الجلدية الخطيرة يكون خلال الأسابيع الأولى من العلاج. إذا كنت قد واجهت متلازمة ستيفنز جونسون أو انحلال البشرة السمي مع استخدام كوكسيكام، يجب أن لا يعاد استخدام كوكسيكام في أي وقت مستقبلاً.</p><p dir="RTL">إذا حدث لك الطفح الجلدي أو هذه الأعراض الجلدية، توقف عن تناول كوكسيكام واطلب المشورة العاجلة من طبيب وأخبره أنك تتناول هذا الدواء.</p><p dir="RTL">كوكسيكام غير مناسب، إذا كنت تحتاج للراحة الفورية من الألم الحاد.</p><p dir="RTL">كوكسيكام قد يخفي أعراض العدوى (مثل الحمى). إذا كنت تعتقد أن لديك عدوى يجب عليك مراجعة الطبيب.</p><p dir="RTL"><strong>احتياطات الاستخدام</strong></p><p dir="RTL">كما سيلزم ضبط العلاج، من المهم أن تطلب نصيحة طبيبك قبل تناول كوكسيكام في الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك تاريخ لالتهاب المريء (المري)، الالتهاب المعدي (التهاب المعدة) أو تاريخ من أي مرض آخر في الجهاز الهضمي، وعلى سبيل المثال مرض أو التهاب القولون التقرحي داء كرون.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستوى ضغط الدم (ارتفاع ضغط الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كبار السن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمراض القلب والكبد أو الكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستويات السكر في الدم (داء السكري)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حجم الدم المنخفض (نقص كمية الدم) التي قد تحدث إذا كان لديك فقد دم خطير أو حرق، أو جراحة أو انخفاض كمية السوائل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستوى عالي من البوتاسيوم بالدم قد تم تشخيصه عن طريق طبيبك</p><p dir="RTL">سيحتاج طبيبك لمراقبة تحسنك أثناء العلاج</p><p dir="RTL"><strong>الأدوية الأخرى وكوكسيكام</strong></p><p dir="RTL">كوكسيكام قد يؤثر على أو يتأثر بأدوية أخرى، أخبر طبيبك أو الصيدلي إذا كنت تتناول، قد تناولت مؤخرا أو قد تتناول أي أدوية أخرى.</p><p dir="RTL">على وجه الخصوص يرجى إخبار الطبيب أو الصيدلي إذا كنت تتناول /تناولت، أو تستخدم أي من الأدوية التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الالتهاب اللاستيرويدية الأخرى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تمنع تخثر الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تكسر تجلط الدم (مذيبات جلطات الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية علاج أمراض القلب والكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الكورتيزون (يستخدم على سبيل المثال ضد الالتهابات أو الحساسية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السيكلوسبورين الذي يستخدم بعد زرع الأعضاء، أو الأمراض الجلدية الحادة، والتهاب المفاصل الروماتويدي أو المتلازمة الكلوية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أي دواء مدر للبول (أقراص &quot;الماء&quot;) طبيبك قد يراقب وظائف الكلى لديك اذا كنت تتناول مدرات البول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دواء لعلاج ارتفاع ضغط الدم (مثل حاصرات بيتا)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الليثيوم - يستخدم لعلاج الاضطرابات النفسية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات إعادة امتصاص السيروتونين الانتقائية (اس اس اراي) - يستخدم في علاج الاكتئاب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الميثوتريكسيت - يستخدم لعلاج الأورام أو الأمراض الجلدية الشديدة الغير مسيطر عليها والتهاب المفاصل الروماتويدي النشط</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كوليستيرامين - تستخدم لخفض مستويات الكولسترول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتي امرأة وتستخدمين جهاز منع الحمل داخل الرحم (اللولب)، عادة ما يعرف باسم الشريط</p><p dir="RTL">إذا كنت في شك، اسأل طبيبك أو الصيدلي.</p><p><strong>الخصوبة</strong></p><p>كوكسيكام قد يجعل الأمر أكثر صعوبة لتصبحي حاملا. يجب إبلاغ الطبيب إذا كنت تخططين لتصبحي حاملا أو إذا كان لديك مشاكل لتصبحي حاملا.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">لا تتناولي كوكسيكام إذا كنت في الأشهر الثلاثة الأخيرة من الحمل لأنه قد يؤذي الجنين أو يسبب مشاكل عند الولادة. <strong>يمكن أن يسبب مشاكل في الكلى والقلب لجنينك الذي لم يولد بعد. قد يؤثر على ميلك أنت وطفلك للنزيف ويتسبب في تأخر المخاض أو تأخره عما هو متوقع.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp; لا يجب أن تتناولي كوكسيكام خلال الأشهر الستة الأولى من الحمل ما لم تكن هناك ضرورة قصوى <strong>ونصح به طبيبك</strong>. إذا كنت بحاجة إلى علاج خلال هذه الفترة أو أثناء محاولتك للحمل، فيجب استخدام أقل جرعة لأقصر وقت ممكن<strong>. إذا تم تناوله لأكثر من بضعة أيام من 20 أسبوعًا من الحمل فصاعدًا. يمكن أن يسبب دواء كوكسيكام مشاكل في الكلى لدى طفلك الذي لم يولد بعد، مما قد يؤدي إلى انخفاض مستويات السائل الأمنيوسي الذي يحيط بالطفل (قلة السائل السلوى) أو تضيق الأوعية الدموية (القناة الشريانية) في قلب الطفل. إذا كنت بحاجة إلى علاج لمدة تزيد عن بضعة أيام، فقد يوصي طبيبك بمراقبة إضافية.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد تحدث اضطرابات بصرية، بما في ذلك عدم وضوح الرؤية، والدوخة، والخمول، والدوار أو اضطرابات أخرى بالجهاز العصبي المركزي. إذا تضررت لا تقود سيارة أو تقوم بتشغيل الآلات</p><p dir="RTL"><strong>معلومات هامة حول بعض مكونات كوكسيكام</strong></p><p dir="RTL">يحتوي كوكسيكام على اللاكتوز والسيليولوز التي تعتبر من أنواع السكريات. إذا تم إعلامك بأنك تعاني من عدم القدرة على تحمل بعض السكريات اسأل طبيبك قبل تناول الدواء</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول دائما هذا الدواء تماما كما قال لك طبيبك. استشر طبيبك أو الصيدلي إذا لم تكن متأكدا.</p><p dir="RTL"><strong>الجرعة الموصى بها هي:</strong></p><p dir="RTL"><strong>نوبات هشاشة العظام:</strong></p><p dir="RTL">7.5 ملجم مرة واحدة يوميا. ويمكن زيادتها إلى 15 ملجم مرة واحدة يوميا.</p><p dir="RTL"><strong>التهاب المفاصل الروماتويدي:</strong></p><p dir="RTL">15 ملجم مرة واحدة يوميا. ويمكن تخفيضها إلى 7.5 ملجم مرة واحدة يوميا.</p><p dir="RTL"><strong>التهاب الفقرات الروماتويدي:</strong></p><p dir="RTL">15 ملجم مرة واحدة يوميا. ويمكن تخفيضها إلى 7.5 ملجم مرة واحدة يوميا.</p><p dir="RTL">يجب ابتلاع الأقراص مع الماء، أو شراب آخر، أثناء وجبة الطعام.</p><p dir="RTL"><strong>لا تتجاوز الجرعة القصوى الموصى &nbsp;بها 15 ملجم يوميا.</strong></p><p dir="RTL">إذا كان أي من البيانات المذكورة تحت عنوان &quot;تحذيرات واحتياطات&quot; تنطبق عليك، فإن طبيبك قد يقيد الجرعة إلى 7.5 ملجم مرة واحدة يوميا.</p><p dir="RTL"><strong>يجب عدم إعطاء كوكسيكام للأطفال والمراهقين تحت سن 16 سنة من العمر.</strong></p><p dir="RTL">إذا كنت تشعر بأن تأثير كوكسيكام قوي جدا او ضعيف جدا، أو إذا بعد عدة أيام كنت لا تشعر بأي تحسن في حالتك، تحدث مع طبيبك أو الصيدلي.</p><p dir="RTL"><strong>إذا تناولت كوكسيكام أكثر مما يجب</strong></p><p dir="RTL"><strong>إذا كنت قد تناولت الكثير من الأقراص أو تشك في جرعة زائدة، اتصل بطبيبك أو اذهب إلى أقرب مستشفى على الفور.</strong></p><p dir="RTL"><strong>الأعراض الحادة التي تتلو الجرعة الزائدة من الأدوية المضادة للالتهاب عادة ما تقتصر على:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم وجود الطاقة (الخمول)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نعاس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالاعياء (الغثيان)، والاعياء فعلاً (القيء)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في منطقة المعدة (ألم شرسوفي)</p><p dir="RTL">هذه الأعراض عادة تتحسن عند التوقف عن تناول كوكسيكام. قد تعاني من نزيف في المعدة أو الأمعاء (النزيف المعوي).</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>التسمم الحاد قد ينتج عنه تفاعلات دوائية خطيرة (انظر القسم 4.):</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضغط الدم العالي (ارتفاع ضغط الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الفشل الكلوي الحاد (بالكلى)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختلال وظيفي كبدي (الكبد)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقليل / تسطح أو توقف التنفس (صعوبة التنفس)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الوعي (الغيبوبة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النوبات (التشنجات)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انهيار الدورة الدموية (انهيار القلب والأوعية الدموية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; توقف القلب (السكتة القلبية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض تحسسية فورية (فرط الحساسية) ، بما في ذلك:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp; الإغماء</p><p dir="RTL">o&nbsp;&nbsp;&nbsp; ضيق في التنفس</p><p dir="RTL">o&nbsp;&nbsp;&nbsp; أعراض جانبية بالجلد</p><p dir="RTL"><strong>إذا نسيت أن تتناول كوكسيكام</strong></p><p dir="RTL">لا تتناول جرعة مضاعفة لتعويض الجرعة المنسية. فقط تناول الجرعة التالية في الوقت المعتاد.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى عن استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن لهذا الدواء أن يسبب آثارا جانبية، على الرغم من أنها لا تحدث للجميع.</p><p dir="RTL"><strong>توقف عن تناول كوكسيكام واستشر الطبيب أو أقرب مستشفى على الفور إذا لاحظت:</strong></p><p dir="RTL">أي أعراض تحسسية (فرط الحساسية) ، التي قد تظهر على شكل:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض جانبية بالجلد، مثل الحكة (حكة)، ظهور تقرحات أو تقشير الجلد، والتي يمكن أن يكون الطفح الجلدي لديه احتمالية مهددة للحياة (متلازمة ستيفنز جونسون، انحلال البشرة السمي)، آفات الأنسجة الرخوة (الآفات المخاطية) أو الحمامي عديدة الأشكال (انظر القسم 2). الحمامي عديدة الأشكال أعراض حساسية خطيرة بالجلد يسبب البقع، بقع حمراء أو أرجوانية أو مناطق متقرحة. ويمكن أن يؤثر أيضا على الفم والعينين وغيرها من أسطح الجسم الرطبة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الجلد أو الغشاء المخاطي، مثل التورم حول العينين والوجه والشفتين والفم أو الحلق، وربما يجعل التنفس صعباً، تورم القدمين أو الساقين (وذمة في الأطراف السفلية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات ضيق في التنفس أو الربو</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الالتهاب الكبدي (التهاب الكبد). هذا يمكن أن يسبب أعراض مثل:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد أو مقل العيون (اليرقان)</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في البطن</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">أي آثار جانبية في الجهاز الهضمي، وخاصة:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النزيف (يسبب براز بلون القطران)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقرح الجهاز الهضمي (يسبب آلام في البطن)</p><p dir="RTL">نزيف في الجهاز الهضمي (نزيف الجهاز الهضمي)، ظهور تقرحات أو تكوين فتحة في الجهاز الهضمي (ثقب) قد يكون في بعض الأحيان شديد وقاتل، وخاصة في كبار السن.</p><p dir="RTL">إذا كنت قد تعرضت في وقت سابق لأي أعراض في الجهاز الهضمي بسبب الاستخدام طويل الأمد من مضادات الالتهاب اللاستيرويدية، اطلب المشورة الطبية على الفور، وخاصة إذا كنت من كبار السن. طبيبك سيراقب تقدمك وانت على العلاج.</p><p dir="RTL">إذا تضررت من الاضطرابات البصرية لا تقود السيارة أو تشغل آلات.</p><p dir="RTL"><strong>الآثار الجانبية العامة للأدوية المضادة للالتهاب اللاستيرويدية (المسكنات)</strong></p><p dir="RTL">استخدام بعض العقاقير المضادة للالتهابات غير الاستيرويدية (مضادات الالتهاب اللاستيرويدية) قد تترافق مع زيادة صغيرة في خطر انسداد الأوعية الشريانية (حدوث الجلطات الشريانية)، على سبيل المثال أزمة قلبية (احتشاء عضلة القلب) أو السكتة الدماغية (السكتة)، وخاصة في الجرعات العالية والعلاج على المدى الطويل.</p><p dir="RTL">وقد تم الإبلاغ عن احتباس السوائل (وذمة)، وارتفاع مستوى ضغط الدم (ارتفاع ضغط الدم) وفشل القلب (قصور القلب) بالاقتران مع العلاج بالأدوية المضادة للالتهاب اللاستيرويدية.</p><p dir="RTL">الآثار الجانبية الأكثر شيوعا الملاحظ أنها تؤثر على الجهاز الهضمي (المعدة والأمعاء الأحداث):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرحة المعدة والجزء العلوي من الأمعاء الصغيرة (قرحة هضمية / بالمعدة أو الاثني عشر)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فتحة في جدار الأمعاء (ثقب) أو نزيف في الجهاز الهضمي (قاتلة في بعض الأحيان، وخاصة في كبار السن)</p><p dir="RTL">وقد تم الإبلاغ عن الآثار الجانبية التالية بعد تناوله الأدوية المضادة للالتهاب:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالإعياء (الغثيان)، أو الإعياء فعلاً (القيء)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; براز رخو (الإسهال)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتفاخ البطن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإمساك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوء الهضم (عسر الهضم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في البطن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البراز بلون القطران بسبب نزيف في الجهاز الهضمي (البراز الأسود)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دم في القيء (قيء دموي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب مع تكوين تقرحات في الفم (التهاب الفم التقرحي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاقم التهابات الجهاز الهضمي (مثل تفاقم التهاب القولون أو مرض داء كرون)</p><p dir="RTL">أقل شيوعا، تمت ملاحظة التهابات المعدة (الالتهاب المعدي).</p><p dir="RTL"><strong>الآثار الجانبية للميلوكسيكام - المادة الفعالة في كوكسيكام</strong></p><p dir="RTL"><strong>شائعة جدا: تؤثر على أكثر من 1 مستخدم لكل 10</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض جانبية بالجهاز الهضمي مثل سوء الهضم (عسر الهضم)، والشعور بالإعياء (الغثيان)، الإعياء فعلاً (القيء)، آلام في البطن، والإمساك، وانتفاخ البطن، براز رخو (الإسهال)</p><p dir="RTL"><strong>شائعة: تؤثر في 1-10 مستخدمين من كل 100</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع</p><p dir="RTL"><strong>غير شائعة: تؤثر في 1-10 مستخدمين من كل 1000</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوخة (الدوار الخفيف)</p><p dir="RTL">شعور الدوخة أو الدوران (الدوار)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الخمول (النعاس)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقر الدم (انخفاض تركيز صبغة الدم الحمراء الهيموغلوبين)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في ضغط الدم (ارتفاع ضغط الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; توهج (احمرار مؤقت في الوجه والرقبة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتباس الصوديوم والماء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات البوتاسيوم (زيادة البوتاسيوم بالدم). هذا يمكن أن يؤدي إلى أعراض مثل:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغييرات فى دقات القلب (عدم انتظام ضربات القلب)</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الخفقان (عندما تشعر دقات قلبك أكثر من المعتاد)</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف العضلات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجشؤ</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب المعدة (التهاب معدي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف في الجهاز الهضمي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهابات بالفم (التهاب الفم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض تحسسية (فرط الحساسية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحكة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التورم الناجم عن احتباس السوائل (وذمة)، بما في ذلك انتفاخ في الكاحلين / الساقين (وذمة في الأطراف السفلية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الجلد المفاجئ أو الغشاء المخاطي، مثل التورم حول العينين والوجه والشفتين والفم أو الحلق، وربما يجعل التنفس صعبة (وذمة وعائية عصبية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات مؤقتة في اختبارات وظائف الكبد (على سبيل المثال رفع أنزيمات الكبد مثل الترانساميناسات أو زيادة صبغة البيليروبين المراري). طبيبك يمكن الكشف عن هذه باستخدام اختبار الدم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب في الاختبارات المعملية بوظيفة الكلى (الفشل الكلوي) (على سبيل المثال رفع الكرياتينين أو اليوريا)</p><p dir="RTL"><strong>نادر: يؤثر في 1-10 مستخدمين من كل 10000</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات المزاج</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الكوابيس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عد الدم غير طبيعي، بما في ذلك:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعداد الدم غير طبيعي</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد خلايا الدم البيضاء</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الصفائح الدموية (الصفيحات)</p><p dir="RTL">هذه الآثار الجانبية يمكن أن تؤدي إلى زيادة خطر العدوى وأعراض مثل كدمات أو نزيف في الأنف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرنين في الأذن (طنين)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بضربات قلبك (خفقان)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرحة المعدة أو الجزء العلوي من الأمعاء الصغيرة (قرحة هضمية / بالمعدة والاثني عشر)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب المريء (المري)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حدوث نوبات الربو (يرى في الناس الذين لديهم حساسية من الأسبرين أو مضادات الالتهاب اللاستيرويدية الأخرى)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ظهور تقرحات شديدة في الجلد أو تقشير (متلازمة ستيفن-جونسون وانحلال البشرة السمي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي القراص (الشرى)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاضطرابات البصرية بما في ذلك:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم وضوح الرؤية</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الملتحمة (التهاب مقلة العين أو الجفون)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأمعاء الغليظة (التهاب القولون)</p><p dir="RTL"><strong>نادرة جدا: يؤثر في أقل من 1 مستخدم لكل 10000</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض التقرح في الجلد (ظهور فقاقيع) والحمامي عديدة الأشكال. الحمامي عديدة الأشكال لها أعراض تحسسية خطيرة بالجلد تسبب البقع، بقع حمراء أو أرجوانية أو تقرح المناطق. ويمكن أن يؤثر أيضا في الفم والعينين وغيرها من أسطح الجسم الرطبة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب كبدي (التهاب الكبد). هذا يمكن أن يسبب أعراض مثل:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد أو مقل العيون (اليرقان)</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم البطن</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل حاد في الكلى (الفشل الكلوي) وبخاصة في المرضى الذين يعانون من عوامل الخطر مثل مرض القلب أو السكري أو أمراض الكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فتحة في جدار الأمعاء (ثقب)</p><p dir="RTL"><strong>غير معروف: لا يمكن تقدير تكرارها من البيانات المتاحة </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الارتباك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التوهان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق في التنفس وأعراض في الجلد (أعراض الحساسية / تأقانية) الطفح الجلدي الناجم عن التعرض لأشعة الشمس (أعراض حساسية للضوء)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تم الإبلاغ عن فشل القلب (قصور القلب) بالاقتران مع العلاج بالأدوية المضادة للالتهاب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان كامل لأنواع معينة من خلايا الدم البيضاء (ندرة المحببات)، وخاصة في المرضى الذين يتناولون كوكسيكام جنبا إلى جنب مع الأدوية الأخرى التي يمكن أن تكون مثبطة، مهدئة أو مدمرة لمكون ما في نخاع العظم (الأدوية السامة للنخاع العظمي). هذا يمكن أن يسبب:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى مفاجئة</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الحلق</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العدوى</p><p dir="RTL"><strong>الآثار الجانبية التي تسببها الأدوية المضادة للالتهاب غير الاستيرويدية (مضادات الالتهاب اللاستيرويدية)، ولكن لم ترى بعد مع تناول كوكسيكام</strong></p><p dir="RTL">تغييرات على بنية الكلى مما يؤدي إلى الفشل الكلوي الحاد:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات نادرة جدا في التهاب الكلى (التهاب الكلي النسيجي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; موت بعض الخلايا داخل الكلى (نخر أنبوبي أو حليمي حاد)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البروتين في البول (المتلازمة الكلوية مع بروتين بالبول)</p><p dir="RTL">إذا كان لديك أي آثار جانبية، تحدث مع طبيبك أو الصيدلي. وهذا يشمل أي آثار جانبية محتملة غير المدرجة في هذه النشرة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ هذا الدواء بعيداً عن مرأي ومتناول الأطفال</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم الدواء بعد تاريخ انتهاء الصلاحية المدون على شريط الأقراص والعبوة تاريخ انتهاء الصلاحية يشير إلى آخر يوم بالشهر المذكور</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30 درجة مئوية بعيداً عن الضوء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في العبوة الأصلية للحماية من الرطوبة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية رمي الأدوية التي لم تعد تستخدم. سوف تساعد هذه التدابير حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">على ماذا يحتوي كوكسيكام</p><p dir="RTL"><strong>أقراص:</strong></p><p dir="RTL">&nbsp;يحتوي كل قرص على ميلوكسيكام (دستور الأدوية البريطاني) 7,5 ملجم أو 15 ملجم.</p><p dir="RTL">المواد الإضافية: مايكروكريستللين سيليلوزpH 102، لاكتوز، بوفيدون k30، كولويدال سيليكا لامائي، كروسبوفيدون، صوديوم سيتريت ومغنيسيوم ستيريت.</p><p dir="RTL"><strong>الشكل الصيدلاني:</strong></p><p dir="RTL"><strong>أقـــراص 5.7 ملجـــم: </strong>أقراص ذات لون أصفر فاتـــح مخضر، دائرية محدبة مـــن الجانبين، بها 16 RP على جانب واحد، وخط فاصل على الجانب الآخر.</p><p dir="RTL"><strong>أقـــراص 15 ملجم: </strong>أقـــراص ذات لون أصفر فاتـــح مخضر، ذات حواف مشطوفه دائرية مسطحة، بها 20 RP على جانب واحد، وخط فاصل على الجانب الآخر<strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>العبوة:</strong> عبوات تحتوي على (10) أقراص من كوكسيكام 7.5 ملجم أو 15 ملجم.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عبوات تحتوي على (30) قرص من كوكسيكام 7.5 ملجم.</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عبوات المستشفيات تحتوي على كوكسيكام 7.5 أو 15 ملجم.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة المنتجات الطبية والتجميلية المحدودة ( الرياض فارما)</p><p dir="RTL">ص.ب. 442 الرياض 11411</p><p dir="RTL">فاكس: 966112650505+</p><p dir="RTL">البريد الإلكتروني: contact@riyadhpharma.com</p><p dir="RTL"><em>لأية معلومات عن هذا المنتج الطبي، يرجى الاتصال على صاحب الترخيص والتسويق:</em></p><p dir="RTL">المملكة العربية السعودية</p><p dir="RTL">قسم التسويق</p><p dir="RTL">الرياض</p><p dir="RTL">تلفون: 966112650111+</p><p dir="RTL">البريد الإلكتروني: marketing@riyadhpharma.com</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            10/2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Coxicam 7.5 & 15 mg Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 7.5 mg of Meloxicam.
Each tablet contains 15 mg of Meloxicam.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablet
7.5 mg tablets: Greenish light yellow coloured, biconvex circular tablets, having RP 16 on one side,
and break line on the other side.
15 mg tablets: Greenish light yellow coloured, flat circular belvelled edged tablets, having RP 20 on
one side, and break line on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- Short-term symptomatic treatment of exacerbations of osteoarthrosis.</p><p>- Long-term symptomatic treatment of rheumatoid arthritis or ankylosing spondylitis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>&nbsp;</p><p>The total daily amount should be taken as a single dose.</p><p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). The patient&#39;s need for symptomatic relief and response to therapy should be re-evaluated periodically, especially in patients with osteoarthritis.</p><p>- Exacerbations of osteoarthrosis: 7.5 mg/day (one 7.5 mg tablet).</p><p>If necessary, in the absence of improvement, the dose may be increased to 15 mg/day (two 7.5 mg tablets).</p><p>- Rheumatoid arthritis, ankylosing spondylitis: 15 mg/day (two 7.5 mg tablets).</p><p>(see also section &#39;Special populations&#39; below)</p><p>According to the therapeutic response, the dose may be reduced to 7.5 mg/day (one 7.5 mg tablet).</p><p>DO NOT EXCEED THE DOSE OF 15 MG/DAY.</p><p><u>&nbsp;</u></p><p><u>Special populations</u></p><p><em>Elderly patients and patients with increased risks for adverse reaction (see section 5.2):</em></p><p>The recommended dose for long term treatment of rheumatoid arthritis and ankylosing spondylitis in elderly patients is 7.5 mg per day. Patients with increased risks for adverse reactions should start treatment with 7.5 mg per day (see section 4.4).</p><p>&nbsp;</p><p><em>Renal impairment (see section 5.2):</em></p><p>In dialysis patients with severe renal failure, the dose should not exceed 7.5 mg per day.</p><p>No dose reduction is required in patients with mild to moderate renal impairment (i.e. patients with a creatinine clearance of greater than 25 ml/min). (For patients with non-dialysed severe renal failure, see section 4.3)</p><p>&nbsp;</p><p><em>Hepatic impairment (see section 5.2):</em></p><p>No dose reduction is required in patients with mild to moderate hepatic impairment (For patients with severely impaired liver function, see section 4.3).</p><p>&nbsp;</p><p><em>Paediatric population:</em></p><p>Coxicam 7.5 mg tablets is contraindicated in children and adolescents aged under 16 years (see section 4.3).</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>For oral use</p><p>Coxicam 7.5mg tablets are swallowed with water or other fluid in conjunction with food.</p><p>This medicinal product exists in other dosages, which may be more appropriate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                This medicinal product is contra-indicated in the following situations:

	hypersensitivity to the active substance or to any of the excipients listed in section 6.1;
	third trimester of pregnancy (see section 4.6 'Fertility, pregnancy and lactation');
	children and adolescents aged under 16 years;
	hypersensitivity to substances with a similar action, e.g. NSAIDs, aspirin. Meloxicam should not be given to patients who have developed signs of asthma, nasal polyps, angioneurotic edema or urticaria following the administration of aspirin or other NSAIDs;
	history of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy;
	active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding);
	severely impaired liver function;
	non-dialysed severe renal failure;
	gastrointestinal bleeding, history of cerebrovascular bleeding or other bleeding disorders;
	severe heart failure.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2, and GI and cardiovascular risks below).</p><p>The recommended maximum daily dose should not be exceeded in case of insufficient therapeutic effect, nor should an additional NSAID be added to the therapy because this may increase the toxicity while therapeutic advantage has not been proven. The use of meloxicam with concomitant NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided.</p><p>Meloxicam is not appropriate for the treatment of patients requiring relief from acute pain.</p><p>In the absence of improvement after several days, the clinical benefit of the treatment should be reassessed.</p><p>Any history of oesophagitis, gastritis and/or peptic ulcer must be sought in order to ensure their total cure before starting treatment with meloxicam. Attention should routinely be paid to the possible onset of a recurrence in patients treated with meloxicam and with a past history of this type.</p><p>&nbsp;</p><p><strong><em>Gastrointestinal effects</em></strong></p><p>GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious GI events.</p><p>The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3), and in the elderly. These patients should commence treatment on the lowest dose available. Combination therapy with protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients requiring concomitant low dose aspirin, or other drugs likely to increase gastrointestinal risk (see below and 4.5).</p><p>Patients with a history of GI toxicity, particularly when elderly, should report any unusual abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment.</p><p>In patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as heparin as curative treatment or given in geriatrics, anticoagulants such as warfarin, other non steroidal anti-inflammatory drugs, or acetylsalicylic acid given at doses &ge;500 mg as single intake or &ge; 3g as total daily amount the combination with meloxicam is not recommended (see section 4.5).</p><p>When GI bleeding or ulceration occurs in patients receiving meloxicam the treatment should be withdrawn.</p><p>NSAIDs should be given with care to patients with a history of gastrointestinal disease (ulcerative colitis, Crohn&#39;s disease) as these conditions may be exacerbated (see section 4.8 &ndash; undesirable effects).</p><p>&nbsp;</p><p><strong><em>Cardiovascular and cerebrovascular effects</em></strong></p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy.</p><p>Clinical monitoring of blood pressure for patients at risk is recommended at baseline and especially during treatment initiation with meloxicam.</p><p>Clinical trial and epidemiological data suggest that use of some NSAIDs including meloxicam (particularly at high doses and in long term treatment) may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). There are insufficient data to exclude such a risk for meloxicam.</p><p>Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with meloxicam after careful consideration. Similar consideration should be made before initiating longer-term treatment of patients with risk factors for cardiovascular disease (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking).</p><p>&nbsp;</p><p><strong><em>Skin reactions</em></strong></p><p>Life-threatening cutaneous reactions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported with the use of Meloxicam. Patients should be advised of the signs and symptoms and monitored closely for skin reactions. The highest risk for occurrence of SJS or TEN is within the first weeks of treatment. If symptoms or signs of SJS or TEN (e.g. progressive skin rash often with blisters or mucosal lesions) are present, Meloxicam treatment should be discontinued. The best results in managing SJS and TEN come from early diagnosis and immediate discontinuation of any suspect drug. Early withdrawal is associated with a better prognosis. If the patient has developed SJS or TEN with the use of Meloxicam, Meloxicam must not be re-started in this patient at any time.</p><p>&nbsp;</p><p><strong><em>Parameters of liver and renal function</em></strong></p><p>As with most NSAIDs, occasional increases in serum transaminase levels, increases in serum bilirubin or other liver function parameters, as well as increases in serum creatinine and blood urea nitrogen and other laboratory disturbances, have been reported. The majority of these instances involved transitory and slight abnormalities. Should any such abnormality prove significant or persistent, the administration of Meloxicam should be stopped and appropriate investigations undertaken.</p><p><strong><em>Functional renal failure</em></strong></p><p>NSAIDs, by inhibiting the vasodilating effect of renal prostaglandins, may induce a functional renal failure by reduction of glomerular filtration. This adverse event is dose-dependant. At the beginning of the treatment, or after dose increase, careful monitoring of diuresis and renal function is recommended in patients with the following risk factors:</p><p>&bull; Elderly</p><p>&bull; Concomitant treatments such as ACE inhibitors, angiotensin-II antagonists, sartans, diuretics (see section 4.5. Interaction with other medicinal products and other forms of interaction)</p><p>&bull; Hypovolemia (whatever the cause)</p><p>&bull; Congestive heart failure</p><p>&bull; Renal failure</p><p>&bull; Nephrotic syndrome</p><p>&bull; Lupus nephropathy</p><p>&bull; Severe hepatic dysfunction (serum albumin &lt;25 g/l or Child-Pugh score &ge;10)</p><p>In rare instance NSAIDs may be the cause of interstitial nephritis, glomerulonephritis, renal medullary necrosis or nephrotic syndrome.</p><p>The dose of meloxicam in patients with end-stage renal failure on haemodialysis should not be higher than 7.5 mg. No dose reduction is required in patients with mild or moderate renal impairment (i.e. in patients with a creatinine clearance of greater than 25 ml/min).</p><p>&nbsp;</p><p><strong><em>Sodium, potassium and water retention</em></strong></p><p>Induction of sodium, potassium and water retention and interference with the natriuretic effects of diuretics may occur with NSAIDs. Furthermore, a decrease of the antihypertensive effect of antihypertensive drugs can occur (see section 4.5). Consequently, oedema, cardiac failure or hypertension may be precipitated or exacerbated in susceptible patients as a result. Clinical monitoring is therefore necessary for patients at risk (see sections 4.2 and 4.3).</p><p>&nbsp;</p><p><strong><em>Hyperkalaemia</em></strong></p><p>Hyperkalaemia can be favoured by diabetes or concomitant treatment known to increase kalaemia (see section 4.5). Regular monitoring of potassium values should be performed in such cases.</p><p>&nbsp;</p><p><strong><em>Combination with pemetrexed</em></strong></p><p>In patients with mild to moderate renal insufficiency receiving pemetrexed, meloxicam should be interrupted for at least 5 days prior to, on the day of, and at least 2 days following pemetrexed administration (see section 4.5).</p><p>&nbsp;</p><p><strong><em>Other warnings and precautions</em></strong></p><p>Adverse reactions are often less well tolerated in elderly, fragile or weakened individuals, who therefore require careful monitoring. As with other NSAIDs, particular caution is required in the elderly, in whom renal, hepatic and cardiac functions are frequently impaired. The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal (see section 4.2).</p><p>Meloxicam, as any other NSAID may mask symptoms of an underlying infectious disease.</p><p>The use of meloxicam may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of meloxicam should be considered (see section 4.6).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Risks related to hyperkalaemia:</u></p><p>Certain medicinal products or therapeutic groups may promote hyperkalaemia: potassium salts, potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists, non-steroidal anti-inflammatory drugs, (low-molecular-weight or unfractionated) heparins, cyclosporin, tacrolimus and trimethoprim.</p><p>The onset of hyperkalaemia may depend on whether there are associated factors.</p><p>This risk is increased when the above-mentioned medicinal products are co-administered with meloxicam.</p><p>&nbsp;</p><p><u>Pharmacodynamic Interactions:</u></p><p><em>Other non steroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid:</em></p><p>combination (see section 4.4) with other non steroidal anti-inflammatory drugs, acetylsalicylic acid given at doses &ge;500 mg as single intake or &ge; 3g as total daily amount is not recommended.</p><p>&nbsp;</p><p><em>Corticosteroids (e.g. Glucocorticoids):</em></p><p>The concomitant use with corticosteroids requests caution because of an increased risk of bleeding or gastrointestinal ulceration.</p><p>&nbsp;</p><p><em>Anticoagulant or heparin:</em></p><p>Considerably increased risk of bleeding, via inhibition of platelet function and damage to the gastroduodenal mucosa. NSAIDs may enhance the effects of anti-coagulants, such as warfarin (see section 4.4). The concomitant use of NSAIDs and anticoagulants or heparin administered in geriatrics or at curative dose is not recommended (see section 4.4).</p><p>In remaining cases (e.g. preventive doses) of heparin use caution is necessary due to an increased bleeding risk.</p><p>Careful monitoring of the INR is required if it proves impossible to avoid such combination.</p><p>&nbsp;</p><p><em>Thrombolytics and antiplatelet drugs:</em></p><p>Increased risk of bleeding, via inhibition of platelet function and damage to the gastroduodenal mucosa.</p><p>&nbsp;</p><p><em>Selective serotonin reuptake inhibitors (SSRIs):</em></p><p>Increased risk of gastrointestinal bleeding.</p><p>&nbsp;</p><p><em>Diuretics, ACE inhibitors and Angiotensin-II Antagonists:</em></p><p>NSAIDs may reduce the effect of diuretics and other antihypertensive drugs. In some patients with compromised renal function (e.g. dehydrated patients or elderly patients with compromised renal function) the co-administration of an ACE inhibitor or Angiotensin-II antagonists and agents that inhibit cyclo-oxygenase may result in further deterioration of renal function, including possible acute renal failure, which is usually reversible. Therefore, the combination should be administered with caution, especially in the elderly. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy, and periodically thereafter (see also section 4.4).</p><p>&nbsp;</p><p><em>Other antihypertensive drugs (e.g. Beta-blockers):</em></p><p>As for the latter, a decrease of the antihypertensive effect of beta-blockers (due to inhibition of prostaglandins with vasodilatory effect) can occur.</p><p>&nbsp;</p><p><em>Calcineurin inhibitors (e.g. cyclosporin, tacrolimus):</em></p><p>Nephrotoxicity of&nbsp;<em>calcineurin inhibitors&nbsp;</em>may be enhanced by NSAIDs via renal prostaglandin mediated effects. During combined treatment renal function is to be measured. A careful monitoring of the renal function is recommended, especially in the elderly.</p><p>&nbsp;</p><p>Intrauterine devices. A decrease of the efficacy of intrauterine devices by NSAIDs has been previously reported but needs further confirmation.</p><p>&nbsp;</p><p><u>Pharmacokinetic Interactions: Effect of meloxicam on the pharmacokinetics of other drugs</u></p><p><em>Lithium:</em></p><p>NSAIDs have been reported to increase blood lithium levels (via decreased renal excretion of lithium), which may reach toxic values. The concomitant use of lithium and NSAIDs is not recommended (see section 4.4). If this combination appears necessary, lithium plasma concentrations should be monitored carefully during the initiation, adjustment and withdrawal of meloxicam treatment.</p><p>&nbsp;</p><p><em>Methotrexate:</em></p><p>NSAIDs can reduce the tubular secretion of methotrexate thereby increasing the plasma concentrations of methotrexate. For this reason, for patients on high dosages of methotrexate (more than 15 mg/week) the concomitant use of NSAIDs is not recommended (see section 4.4).</p><p>The risk of an interaction between NSAID preparations and methotrexate, should be considered also in patients on low dosage of methotrexate, especially in patients with impaired renal function. In case combination treatment is necessary blood cell count and the renal function should be monitored. Caution should be taken in case both NSAID and methotrexate are given within 3 days, in which case the plasma level of methotrexate may increase and cause increased toxicity.</p><p>Although the pharmacokinetics of methotrexate (15mg/week) were not relevantly affected by concomitant meloxicam treatment, it should be considered that the haematological toxicity of methotrexate can be amplified by treatment with NSAID drugs (see above). (See section 4.8)</p><p>&nbsp;</p><p><em>Pemetrexed:</em></p><p>For the concomitant use of meloxicam with pemetrexed in patients with mild to moderate renal impairment (creatinine clearance from 45 to 79 ml/min), the administration of meloxicam should be paused for 5 days before, on the day of, and 2 days following pemetrexed administration. If a combination of meloxicam with pemetrexed is necessary, patients should be closely monitored, especially for myelosuppression and gastro-intestinal adverse reactions. In patients with severe renal impairment (creatinine clearance below 45 ml/min) the concomitant administration of meloxicam with pemetrexed is not recommended.</p><p>In patients with normal renal function (creatinine clearance &ge; 80 ml/min), doses of 15 mg meloxicam may decrease pemetrexed elimination and, consequently, increase the occurrence of pemetrexed adverse events. Therefore, caution should be exercised when administering 15 mg meloxicam concurrently with pemetrexed to patients with normal function (creatinine clearance &ge; 80 ml/min).</p><p><u>Pharmacokinetic Interactions: Effect of other drugs on the pharmacokinetics of meloxicam</u></p><p><em>Cholestyramine:</em></p><p>Cholestyramine accelerates the elimination of meloxicam by interrupting the enterohepatic circulation so that clearance for meloxicam increases by 50% and the half-life decreases to 13<u>+</u>3 hrs. This interaction is of clinical significance.</p><p>No clinically relevant pharmacokinetic drug-drug interactions were detected with respect to the concomitant administration of antacids, cimetidine and digoxin.</p><p><u>Paediatric population</u></p><p>Interaction studies have only been performed in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy and Breastfeeding</strong></p><p><strong>&nbsp;</strong></p><p><strong>From the 20<sup>th</sup> week of pregnancy on ward, coxicam use may cause oligohydramnios resulting from foetal renal dysfunction. This may occur shortly after treatment initiation and is usually reversible upon discontinuation, in addition there have been reports of ductus arteriosus constriction following treatment in the second trimester, most of which resolve after treatment cessation.</strong> <strong>Therefore</strong>, during the first and second trimesters of pregnancy, coxicam should not be given unless clearly necessary.&nbsp; If coxicam is used by a woman trying to conceive, or during the first and second trimesters of pregnancy, the dose should be kept low and the duration of treatment as short as possible.&nbsp; <strong>Antenatal monitoring for oligohydramnios and ductus arteriosus constriction should be considered after exposure to coxicam for several days from gestational week 20 onwards.&nbsp;coxicam should be discontinued if hypoamniotic fluid or ductus arteriosus constriction is found</strong>.&nbsp;</p><p>&nbsp;</p><p>During the last trimester of pregnancy, all inhibitors of fetal prostaglandin synthesis may expose the foetus to:</p><ul><li>cardiopulmonary toxicity (with premature constriction/closure of the ductus arteriosus and pulmonary hypertension).</li><li>Renal impairment (see above)</li></ul><p>&nbsp;</p><p>Mother and neonate, at the end of pregnancy, to:</p><ul><li>Possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses</li><li>Inhibition of uterine contractions resulting in delayed or prolonged labour.</li></ul><p>&nbsp;</p><p>Consequently, coxicam is contraindicated during the third trimester of pregnancy (see sections 4.3 and 5.3)</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Fertility</strong></p><p>&nbsp;</p><p>The use of meloxicam, as with any drug known to inhibit cyclooxygenase/prostaglandin synthesis, may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of meloxicam should be considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No specific studies on the effect on the ability to drive and use machineries have been performed. However, on the basis of the pharmacodynamic profile and reported adverse drug reactions, meloxicam is likely to have no or negligible influence on these abilities. However, when visual disturbances including blurred vision, dizziness, drowsiness, vertigo or other central nervous system disturbances occur, it is advisable to refrain from driving and operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>a) General Description<br />Clinical trial and epidemiological data suggest that use of some NSAIDs (particularly at high doses and in long<br />term treatment) may be associated with a small increased risk of arterial thrombotic events (for example<br />myocardial infarction or stroke) (see section 4.4).<br />Oedema, hypertension, and cardiac failure, have been reported in association with NSAID treatment.<br />The most commonly-observed adverse events are gastrointestinal in nature. Peptic ulcers, perforation or GI<br />bleeding, sometimes fatal, particularly in the elderly, may occur (see section 4.4). Nausea, vomiting, diarrhoea,<br />flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, exacerbation of<br />colitis and Crohn&#39;s disease (see section 4.4 - Special warnings and precautions for use) have been reported<br />following administration. Less frequently, gastritis has been observed.<br />Severe cutaneous adverse reactions (SCARs): Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis<br />(TEN) have been reported (see section 4.4).<br />The frequencies of adverse drug reactions given below are based on corresponding occurrences of reported<br />adverse events in 27 clinical trials with a treatment duration of at least 14 days. The information is based on<br />clinical trials involving 15197 patients who have been treated with daily oral doses of 7.5 or 15 mg meloxicam<br />tablets or capsules over a period of up to one year.<br />Adverse drug reactions that have come to light as a result of reports received in relation to administration of the<br />marketed product are included.<br />Adverse reactions have been ranked under headings of frequency using the following convention:<br />Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to<br />&lt;1/1,000); very rare (&lt;1/10,000), not known (cannot be estimated from the available data)<br />b) Table of adverse reactions<br />Blood and lymphatic system disorders<br />Uncommon: Anaemia<br />Rare: Blood count abnormal (including differential white cell count), leukopenia,<br />thrombocytopenia<br />Very rare cases of agranulocytosis have been reported (see section c).<br />Immune system disorders<br />Uncommon: Allergic reactions other than anaphylactic or anaphylactoid reactions<br />Not known: Anaphylactic reaction, anaphylactoid reaction<br />Psychiatric disorders<br />Rare: Mood altered, nightmares<br />Not known: Confusional state, disorientation<br />Nervous system disorders<br />Common: Headache<br />Uncommon: Dizziness, somnolence<br />Eye disorders<br />Rare: Visual disturbance including vision blurred; conjunctivitis<br />Ear and labyrinth disorders<br />Uncommon: Vertigo<br />Rare: Tinnitus<br />Cardiac disorders<br />Rare: Palpitations<br />Cardiac failure has been reported in association with NSAID treatment.<br />Vascular disorders<br />Uncommon: Blood pressure increased (see section 4.4), flushing<br />Respiratory, thoracic and mediastinal disorders<br />Rare: Asthma in individuals allergic to aspirin or other NSAIDs<br />Gastrointestinal disorders<br />Very common: Gastrointestinal disorders such as dyspepsia, nausea, vomiting, abdominal pain,<br />constipation, flatulence, diarrhoea<br />Uncommon: Occult or macroscopic gastrointestinal haemorrhage, stomatitis, gastritis, eructation<br />Rare: Colitis, gastroduodenal ulcer, oesophagitis<br />Very rare: Gastrointestinal perforation<br />Not known: Pancreatitis<br />Gastrointestinal haemorrhage, ulceration or perforation may sometimes be severe and potentially fatal,<br />especially in elderly (see section 4.4).<br />Hepatobiliary disorders<br />Uncommon: Liver function disorder (e.g. raised transaminases or bilirubin)<br />Very rare: Hepatitis<br />Skin and subcutaneous tissue disorders<br />Uncommon: Angioedema, pruritus, rash<br />Rare: Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria<br />Very rare: Dermatitis bullous, erythema multiforme<br />Not known: Photosensitivity reaction<br />Renal and urinary disorders<br />Uncommon: Sodium and water retention, hyperkalaemia (see section 4.4.Special warnings and<br />precautions for use and section 4.5.), renal function test abnormal (increased serum<br />creatinine and/or serum urea)<br />Very rare: Acute renal failure in particular in patients with risk factors (see section 4.4.)<br />General disorders and administration site conditions<br />Uncommon: Oedema including oedema of the lower limbs.<br />c) Information Characterising Individual Serious and/or Frequently Occurring Adverse Reactions<br />Very rare cases of agranulocytosis have been reported in patients treated with meloxicam and other potentially<br />myelotoxic drugs (see section 4.5).<br />d) Adverse reactions which have not been observed yet in relation to the product, but which are generally<br />accepted as being attributable to other compounds in the class<br />Organic renal injury probably resulting in acute renal failure: very rare cases of interstitial nephritis, acute tubular<br />necrosis, nephrotic syndrome, and papillary necrosis have been reported (see section 4.4).<br />Reporting of suspected adverse reactions<br />To report any side effects<br />- National Pharmacovigilance and Drug Safety Center (NPC)<br />o Fax: +966-11-205-7662<br />o To call the executive management of vigilance and crisis management: +966-11-2038222 ext.: 2353 &ndash; 2356 &ndash;<br />2317 &ndash; 2354 &ndash; 2334 &ndash; 2340<br />o Toll-free: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />United Arab Emirates<br />Pharmacovigilance &amp; Medical device Section<br />&bull;P.O. Box: 1853<br />Tel: 80011111<br />&bull; E-mail: pv@mohap.gov.ae<br />&bull; Drug Department<br />&bull; Ministry of Health &amp; Prevention<br />&bull;Dubai</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms<br />Symptoms following acute NSAID overdose are usually limited to lethargy, drowsiness, nausea, vomiting and<br />epigastric pain, which are generally reversible with supportive care. Gastrointestinal bleeding can occur. Severe<br />poisoning may result in hypertension, acute renal failure, hepatic dysfunction, respiratory depression, coma,<br />convulsions, cardiovascular collapse and cardiac arrest. Anaphylactoid reactions have been reported with<br />therapeutic ingestion of NSAIDs and may occur following an overdose.<br />Treatment<br />Patients should be managed with symptomatic and supportive care following an NSAID overdose. Accelerated<br />removal of meloxicam by 4 g oral doses of cholestyramine given three times a day was demonstrated in a clinical<br />trial.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Non Steroidal Anti-Inflammatory agent, Oxicams<br />ATC code: M01AC06<br />Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory,<br />analgesic and antipyretic properties.<br />The anti-inflammatory activity of meloxicam has been proven in classical models of inflammation. As with other<br />NSAIDs, its precise mechanism of action remains unknown. However, there is at least one common mode of<br />action shared by all NSAIDs (including Meloxicam): inhibition of the biosynthesis of prostaglandins, known<br />inflammation mediators.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Meloxicam is well absorbed from the gastrointestinal tract, which is reflected by a high absolute bioavailability of<br />about 90% following oral administration (capsule). Tablets, oral suspension and capsules were shown to be<br />bioequivalent.<br />Following single dose administration of meloxicam, median maximum plasma concentrations are achieved within<br />2 hours for the suspension and within 5-6 hours with solid oral dosage forms (capsules and tablets).<br />With multiple dosing, steady state conditions were reached within 3 to 5 days. Once daily dosing leads to mean<br />drug plasma concentrations with a relatively small peak-trough fluctuation in the range of 0.4 - 1.0 &mu;g/mL for 7.5<br />mg doses and 0.8 - 2.0 &mu;g/mL for 15 mg doses, respectively (Cmin and Cmax at steady state, correspondingly).<br />Mean maximum plasma concentrations of meloxicam at steady state are achieved within five to six hours for the<br />tablet, capsule and the oral suspension, respectively. Extent of absorption for meloxicam following oral<br />administration is not altered by concomitant food intake or the use of inorganic antacids.<br />Distribution<br />Meloxicam is very strongly bound to plasma proteins, essentially albumin (99%). Meloxicam penetrates into<br />synovial fluid to give concentrations approximately half of those in plasma.<br />Volume of distribution is low, i.e. approx. 11 L after i.m. or i.v. administration, and shows interindividual<br />variation in the order of 7 - 20%. The volume of distribution following administration of multiple oral doses of<br />meloxicam (7.5 to 15 mg) is about 16 L with coefficients of variation ranging from 11 to 32%.<br />Biotransformation<br />Meloxicam undergoes extensive hepatic biotransformation. Four different metabolites of meloxicam were<br />identified in urine, which are all pharmacodynamically inactive. The major metabolite, 5&#39;-carboxymeloxicam<br />(60% of dose), is formed by oxidation of an intermediate metabolite 5&#39;- hydroxymethylmeloxicam, which is also<br />excreted to a lesser extent (9% of dose). In vitro studies suggest that CYP 2C9 plays an important role in this<br />metabolic pathway, with a minor contribution from the CYP 3A4 isoenzyme. The patient&#39;s peroxidase activity is<br />probably responsible for the other two metabolites, which account for 16% and 4% of the administered dose<br />respectively.<br />Elimination<br />Meloxicam is excreted predominantly in the form of metabolites and occurs to equal extents in urine and faeces.<br />Less than 5% of the daily dose is excreted unchanged in faeces, while only traces of the parent compound are<br />excreted in urine.<br />The mean elimination half-life varies between 13 and 25 hours after oral, i.m. and i.v. administration. Total<br />plasma clearance amounts about 7 &ndash; 12 mL/min following single doses orally, intravenously or rectally<br />administered.<br />Linearity/non-linearity<br />Meloxicam demonstrates linear pharmacokinetics in the therapeutic dose range of 7.5 mg 15 mg following per<br />oral or intramuscular administration.<br />Special populations<br />Patients with hepatic/renal insufficiency:<br />Neither hepatic, nor mild to moderate renal insufficiency has a substantial effect on meloxicam pharmacokinetics.<br />Subjects with moderate renal impairment had significant higher total drug clearance. A reduced protein binding is<br />observed in patients with terminal renal failure. In terminal renal failure, the increase in the volume of distribution<br />may result in higher free meloxicam concentrations, and a daily dose of 7.5 mg must not be exceeded (see section<br />4.2).<br />Elderly:<br />Elderly male subjects exhibited similar mean pharmacokinetic parameters compared to those of young male<br />subjects. Elderly female patients showed higher AUC-values and longer elimination half-lives compared to those<br />of young subjects of both genders. Mean plasma clearance at steady state in elderly subjects was slightly lower<br />than that reported for younger subjects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The toxicological profile of meloxicam has been found in preclinical studies to be identical to that of NSAIDs:<br />gastrointestinal ulcers and erosions, renal papillary necrosis at high doses during chronic administration in two<br />animal species.<br />Oral reproductive studies in the rat have shown a decrease of ovulations and inhibition of implantations and<br />embryotoxic effects (increase of resorptions) at maternotoxic dose levels at 1mg/kg and higher. Studies of toxicity<br />on reproduction in rats and rabbits did not reveal teratogenicity up to oral doses of 4 mg/kg in rats and 80 mg/kg<br />in rabbits.<br />The affected dose levels exceeded the clinical dose (7.5-15 mg) by a factor of 10 to 5-fold on a mg/kg dose basis<br />(75 kg person). Fetotoxic effects at the end of gestation, shared by all prostaglandin synthesis inhibitors, have<br />been described. No evidence has been found of any mutagenic effect, either in vitro or in vivo. No carcinogenic<br />risk has been found in the rat and mouse at doses far higher than those used clinically.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline Cellulose PH 102<br />Lactose (100 mesh)<br />Povidone (K30)<br />Colloidal Anhydrous Silica<br />Crospovidone<br />Sodium Citrate (mesh 45)<br />Magnesium Stearate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.<br />Store in the original package in order to protect from light &amp; moisture.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Transparent PVC-PVDC film / Aluminium foil blister pack of 10 tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.<br />Keep medicines out of reach of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)
P.O.Box 442, Riyadh 11411
Fax: +966 11 265 0505
Email: contact@riyadhpharma.com
For any information about this medicinal product, please contact the local representative of
marketing authorisation holder:
Saudi Arabia
Marketing department
Riyadh
Tel: +966 11 265 0111
Email: marketing@riyadhpharma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>